Difference between revisions of "Team:Aachen/Composite Part"
(→Application) |
|||
Line 11: | Line 11: | ||
− | + | Biology and USage | |
In order to upregulate the whole glycogen synthesis pathway, the polycistronic plasmid was built. The glgC coding sequence is based on the part BBa_K118016 from Team Edinburgh 2008, but he RBS B0034 was added to the existing Biobrick. The construct was confirmed by sequencing. The expression of all three enzymes GlgC, GlgA and GlgB was tested in Bl21 Gold (DE3) strains containing BBa_K1585321 in a pSB1A30 expression vector. | In order to upregulate the whole glycogen synthesis pathway, the polycistronic plasmid was built. The glgC coding sequence is based on the part BBa_K118016 from Team Edinburgh 2008, but he RBS B0034 was added to the existing Biobrick. The construct was confirmed by sequencing. The expression of all three enzymes GlgC, GlgA and GlgB was tested in Bl21 Gold (DE3) strains containing BBa_K1585321 in a pSB1A30 expression vector. | ||
− | {{Team:Aachen/Figure|Aachen_glgCAB for registry.png|title=SDS-PAGE of ''glgCAB'' in pSB1A30|subtitle=''glgCAB'' in pSB1A30 was expressed in Bl21 Gold (DE3) strains and IPTG induced. The small arrows indicates the expected bands for all three enzymes . The Bl21 Gold (DE3) wild type was used as the negative control.|size= | + | {{Team:Aachen/Figure|Aachen_glgCAB for registry.png|title=SDS-PAGE of ''glgCAB'' in pSB1A30|subtitle=''glgCAB'' in pSB1A30 was expressed in Bl21 Gold (DE3) strains and IPTG induced. The small arrows indicates the expected bands for all three enzymes . The Bl21 Gold (DE3) wild type was used as the negative control.|size=large}} |
{{Team:Aachen/Footer|color=green}} | {{Team:Aachen/Footer|color=green}} |
Revision as of 13:26, 18 September 2015